SS Retail GMP Surge: Why ₹137 Triggered a Search Spike
SS Retail’s grey‑market premium surged to ₹137 in September 2026, sparking a 75% Google search spike. The article explains the GMP’s volatility, subscription levels, and why retail investors were curious.
11 Oct 2026, 18:54 UTC

Why SS Retail’s Grey‑Market Premium Spike Sparked a Search Surge
In mid‑September 2026 the term ss retail gmp climbed to the top of Google Trends in India. The spike was driven by a volatile grey‑market premium (GMP) that swung from ₹80 to ₹137 and by strong subscription momentum that highlighted the IPO’s popularity among investors.
What is a Grey‑Market Premium?
The GMP is an unofficial price quoted by market participants for a share before it opens on the stock exchange. It reflects the perceived value of the issue and can influence investor sentiment, but it is not a binding price and can change before the first trading day source.
GMP Movements During the Issue Period
| Date | GMP (₹) |
|---|---|
| 11 Sep | ₹80 |
| 12 Sep | ₹106 |
| 13 Sep | ₹120 |
| 14 Sep | ₹140 |
| 15 Sep | ₹128 |
| 16 Sep | ₹90 |
| 17–18 Sep | ₹137 |
On 18 September the GMP reached ₹137, implying an estimated listing price of ₹561 against the ₹424 issue price – a 32.31% premium over the issue price source.
Subscription Momentum on Day 3
By 11:11 AM on 18 September the issue was 13.75× subscribed. The subscription was dominated by non‑institutional investors (NII) at 33.14×, followed by retail investors at 14.05×, employees at 1.29× and QIBs at 0.30× source.
Google Trends: The Search Spike
Google Trends recorded roughly 1,000 searches for the term ss retail gmp with a 75% growth in the 24‑hour period around 18–19 September 2026 source.
What This Means for Retail Investors
- The GMP’s rise to ₹137 indicates strong demand, but it is an unofficial metric and can change before the first trading day.
- High subscription multiples, especially from NII, show investor enthusiasm.
- Search interest reflects the market’s curiosity about the potential upside.
- Investors should treat the GMP as a signal, not a guarantee of post‑listing performance.
Sources & further reading
0 replies
A thoughtful contribution can make all the difference. Be the first to share one.